Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| endothelial cell | 26 studies | 29% ± 13% | |
| endothelial cell of lymphatic vessel | 18 studies | 36% ± 9% | |
| plasmacytoid dendritic cell | 17 studies | 34% ± 10% | |
| oligodendrocyte precursor cell | 15 studies | 53% ± 21% | |
| classical monocyte | 10 studies | 28% ± 11% | |
| dendritic cell | 10 studies | 38% ± 18% | |
| conventional dendritic cell | 9 studies | 27% ± 20% | |
| endothelial cell of artery | 9 studies | 25% ± 6% | |
| non-classical monocyte | 7 studies | 26% ± 9% | |
| fibroblast | 7 studies | 24% ± 13% | |
| vein endothelial cell | 7 studies | 25% ± 14% | |
| monocyte | 7 studies | 30% ± 13% | |
| capillary endothelial cell | 6 studies | 18% ± 2% | |
| retina horizontal cell | 6 studies | 16% ± 1% | |
| GABAergic neuron | 5 studies | 29% ± 6% | |
| epithelial cell | 5 studies | 23% ± 5% | |
| endothelial cell of vascular tree | 5 studies | 33% ± 22% | |
| smooth muscle cell | 4 studies | 27% ± 5% | |
| retinal ganglion cell | 4 studies | 26% ± 4% | |
| myeloid cell | 4 studies | 23% ± 5% | |
| glutamatergic neuron | 4 studies | 31% ± 14% | |
| astrocyte | 3 studies | 19% ± 4% | |
| B cell | 3 studies | 17% ± 1% | |
| connective tissue cell | 3 studies | 25% ± 7% | |
| interneuron | 3 studies | 31% ± 13% | |
| basal cell | 3 studies | 34% ± 17% | |
| mesothelial cell | 3 studies | 26% ± 4% | |
| neuron | 3 studies | 24% ± 4% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 4 studies | 25% ± 1% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 7990.70 | 1445 / 1445 | 97% | 111.97 | 178 / 183 |
| breast | 100% | 6593.51 | 459 / 459 | 96% | 136.53 | 1077 / 1118 |
| intestine | 100% | 5252.45 | 966 / 966 | 93% | 78.65 | 492 / 527 |
| brain | 96% | 3120.02 | 2527 / 2642 | 97% | 144.40 | 687 / 705 |
| kidney | 100% | 6631.21 | 89 / 89 | 89% | 85.88 | 800 / 901 |
| thymus | 100% | 6444.32 | 651 / 653 | 88% | 45.21 | 533 / 605 |
| uterus | 100% | 21833.29 | 170 / 170 | 86% | 87.20 | 396 / 459 |
| stomach | 88% | 2437.61 | 315 / 359 | 91% | 82.94 | 261 / 286 |
| lung | 96% | 2611.42 | 554 / 578 | 70% | 52.63 | 814 / 1155 |
| bladder | 100% | 3756.52 | 21 / 21 | 62% | 53.81 | 313 / 504 |
| ovary | 100% | 20602.68 | 180 / 180 | 46% | 20.14 | 198 / 430 |
| skin | 87% | 3522.77 | 1573 / 1809 | 55% | 31.34 | 258 / 472 |
| adrenal gland | 91% | 1665.81 | 236 / 258 | 48% | 40.72 | 111 / 230 |
| liver | 95% | 2540.27 | 214 / 226 | 39% | 24.22 | 157 / 406 |
| prostate | 98% | 3690.24 | 241 / 245 | 35% | 9.20 | 174 / 502 |
| pancreas | 27% | 420.33 | 88 / 328 | 92% | 100.96 | 163 / 178 |
| adipose | 100% | 8037.86 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 99% | 4607.38 | 1328 / 1335 | 0% | 0 | 0 / 0 |
| heart | 96% | 2676.26 | 824 / 861 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 89% | 91.33 | 40 / 45 |
| peripheral blood | 74% | 3196.89 | 685 / 929 | 0% | 0 | 0 / 0 |
| muscle | 63% | 1052.51 | 507 / 803 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 62% | 28.01 | 18 / 29 |
| spleen | 60% | 897.35 | 144 / 241 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 33% | 11.14 | 26 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0003094 | Biological process | glomerular filtration |
| GO_0090263 | Biological process | positive regulation of canonical Wnt signaling pathway |
| GO_0035860 | Biological process | glial cell-derived neurotrophic factor receptor signaling pathway |
| GO_2000345 | Biological process | regulation of hepatocyte proliferation |
| GO_0014846 | Biological process | esophagus smooth muscle contraction |
| GO_0001822 | Biological process | kidney development |
| GO_0032836 | Biological process | glomerular basement membrane development |
| GO_0030201 | Biological process | heparan sulfate proteoglycan metabolic process |
| GO_0002063 | Biological process | chondrocyte development |
| GO_0097421 | Biological process | liver regeneration |
| GO_0048706 | Biological process | embryonic skeletal system development |
| GO_0010575 | Biological process | positive regulation of vascular endothelial growth factor production |
| GO_1904472 | Biological process | positive regulation of endothelin production |
| GO_0060348 | Biological process | bone development |
| GO_0060384 | Biological process | innervation |
| GO_0051216 | Biological process | cartilage development |
| GO_0009611 | Biological process | response to wounding |
| GO_0030177 | Biological process | positive regulation of Wnt signaling pathway |
| GO_0040037 | Biological process | negative regulation of fibroblast growth factor receptor signaling pathway |
| GO_0005795 | Cellular component | Golgi stack |
| GO_0005615 | Cellular component | extracellular space |
| GO_0005576 | Cellular component | extracellular region |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0009986 | Cellular component | cell surface |
| GO_0005783 | Cellular component | endoplasmic reticulum |
| GO_0004065 | Molecular function | arylsulfatase activity |
| GO_0005539 | Molecular function | glycosaminoglycan binding |
| GO_0005509 | Molecular function | calcium ion binding |
| GO_0008449 | Molecular function | N-acetylglucosamine-6-sulfatase activity |
| Gene name | SULF2 |
| Protein name | Sulfatase 2 Extracellular sulfatase Sulf-2 (hSulf-2) (Arylsulfatase) (EC 3.1.6.1) (N-acetylglucosamine-6-sulfatase) (EC 3.1.6.14) [Cleaved into: Extracellular sulfatase Sulf-2 secreted form] SULF2 protein |
| Synonyms | UNQ559/PRO1120 KIAA1247 |
| Description | FUNCTION: Exhibits arylsulfatase activity and highly specific endoglucosamine-6-sulfatase activity . It can remove sulfate from the C-6 position of glucosamine within specific subregions of intact heparin . . |
| Accessions | H0Y872 Q8IWU5 ENST00000359930.8 [Q8IWU5-1] ENST00000495544.5 Q5BKT1 ENST00000484875.5 [Q8IWU5-1] A0A8V8TMY2 ENST00000698128.1 B1AMP9 ENST00000437955.1 ENST00000688720.1 [Q8IWU5-1] ENST00000467815.5 [Q8IWU5-2] Q6DKK3 |